In apparent contradiction with the evidence of TNF as a driver of Treg immune suppression, several studies have reported that, in RA patients, anti‐TNF therapy leads to the expansion and/or function improvements of Tregs [49, 50, 51, 52]. This evidence concerns the gene TNF and rheumatoid arthritis.